Novartis Ag (NVS) Enterprise Value (2017 - 2025)
Novartis Ag (NVS) has disclosed Enterprise Value for 9 consecutive years, with -$2.7 billion as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 80.11% to -$2.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 billion through Dec 2025, up 80.11% year-over-year, with the annual reading at -$2.7 billion for FY2025, 80.11% up from the prior year.
- Enterprise Value hit -$2.7 billion in Q4 2025 for Novartis Ag, up from -$13.5 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.7 billion in Q4 2025 to a low of -$28.3 billion in Q4 2021.
- Historically, Enterprise Value has averaged -$15.6 billion across 5 years, with a median of -$14.4 billion in 2023.
- Biggest five-year swings in Enterprise Value: crashed 145.0% in 2021 and later skyrocketed 80.11% in 2025.
- Year by year, Enterprise Value stood at -$28.3 billion in 2021, then soared by 33.18% to -$18.9 billion in 2022, then rose by 23.78% to -$14.4 billion in 2023, then rose by 6.73% to -$13.5 billion in 2024, then surged by 80.11% to -$2.7 billion in 2025.
- Business Quant data shows Enterprise Value for NVS at -$2.7 billion in Q4 2025, -$13.5 billion in Q4 2024, and -$14.4 billion in Q4 2023.